Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer

Name: Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
License: Public Domain

National Cancer Centre, Singapore · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

head-and-neck-cancer

head and neck cancer

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 28333 · SHA-256 17c3746fc8cd5ac2
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.